Current market catalysts

Piper Sandler Initiates Coverage On Intel with Neutral Rating, Announces Price Target of $110

Piper Sandler analyst David O'Connor initiates coverage on Intel (NASDAQ:INTC) with a Neutral rating and announces Price Target of $110.

JP Morgan Downgrades United Rentals to Neutral, Lowers Price Target to $1170

JP Morgan analyst Tami Zakaria downgrades United Rentals (NYSE:URI) from Overweight to Neutral and lowers the price target from $1235 to $1170.

Cantor Fitzgerald Maintains Overweight on Hyperliquid Strategies, Raises Price Target to $34.2

Cantor Fitzgerald analyst Gareth Gacetta maintains Hyperliquid Strategies (NASDAQ:PURR) with a Overweight and raises the price target from $22.6 to $34.2.

JP Morgan Upgrades Meta Platforms to Overweight, Raises Price Target to $820

JP Morgan analyst Doug Anmuth upgrades Meta Platforms (NASDAQ:META) from Neutral to Overweight and raises the price target from $640 to $820.

Macy’s Weak Profit Outlook Sends Stock Lower

Macy's (NYSE: M) stock fell in premarket trading despite a Q2 EPS beat as its weak Q3 earnings outlook weighed on investor sentiment.

Cantor Fitzgerald Maintains Overweight on Hyperion DeFi, Raises Price Target to $11.2

Cantor Fitzgerald analyst Gareth Gacetta maintains Hyperion DeFi (NASDAQ:HYPD) with a Overweight and raises the price target from $7.1 to $11.2.

8-K filing — Versus Systems Inc. (VS)

Filed: 2026-09-10 AccNo: 0001213900-26-098586 Size: 190 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

European Central Bank Raises Main Refinancing Rate From 2.40% To 2.65%

$5,000 'Trump Dividend' Echoes Past Promises: Will Bitcoin Rally Again?

Trump pledges a $5,000 dividend if Republicans keep Congress, reviving a stimulus playbook that previously sent Bitcoin sharply higher.

Jefferies Initiates Coverage On Adlai Nortye with Buy Rating, Announces Price Target of $31

Jefferies analyst Maury Raycroft initiates coverage on Adlai Nortye (NASDAQ:ANL) with a Buy rating and announces Price Target of $31.

Apple’s Foldable iPhone Could Trigger a Massive 'Upgrade Cycle,' Says Gary Black — But This One Problem Could Cap 'Incremental Earnings' for 6 Months

Gary Black predicts Apple's foldable phone will drive a new upgrade cycle but hamper incremental earnings for 6 months.

Cantor Fitzgerald Maintains Overweight on Forward Industries, Raises Price Target to $16

Cantor Fitzgerald analyst Gareth Gacetta maintains Forward Industries (NASDAQ:FWDI) with a Overweight and raises the price target from $8 to $16.

Anglogold Ashanti shares are trading lower after BMO Capital downgraded the stock from Outperform to Market Perform rating and maintained the price target at $115.

8-K filing — ONCOLYTICS BIOTECH INC (ONCY)

Filed: 2026-09-10 AccNo: 0001129928-26-000055 Size: 161 KB Item 8.01: Other Events

Cantor Fitzgerald Maintains Overweight on DeFi Development, Raises Price Target to $10.4

Cantor Fitzgerald analyst Gareth Gacetta maintains DeFi Development (NASDAQ:DFDV) with a Overweight and raises the price target from $4.7 to $10.4.

Oncolytics Biotech Announces Pelareorep Lowered Tumor Growth Compared To Control During Initial Treatment Period

Oncolytics Biotech® Inc. (NASDAQ:ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced positive preclinical results evaluating pelareorep in

8-K filing — Candel Therapeutics, Inc. (CADL)

Filed: 2026-09-10 AccNo: 0001193125-26-387310 Size: 231 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Cantor Fitzgerald Maintains Overweight on Cypherpunk Technologies, Raises Price Target to $4.9

Cantor Fitzgerald analyst Gareth Gacetta maintains Cypherpunk Technologies (NASDAQ:CYPH) with a Overweight and raises the price target from $1.6 to $4.9.

Freedom Broker Upgrades Caterpillar to Buy, Announces $980 Price Target

Freedom Broker analyst Sergey Glinyanov upgrades Caterpillar (NYSE:CAT) from Hold to Buy and announces $980 price target.

Is Invesco Large Cap Growth ETF (PWB) a Strong ETF Right Now?

The article provides an in-depth analysis of Invesco Large Cap Growth ETF (PWB), a smart beta ETF launched in 2005 that tracks the Dynamic Large Cap Growth Intellidex Index. With $2.51 billion in assets and a 0.55% expense ratio, PWB offers exposure to large-cap growth stocks with heavy allocation to Information Technology (51.9%). Year-to-date returns are 23.69%, though the fund carries medium risk with a beta of 1.23. The article also compares PWB to alternatives like Vanguard Morningstar Growth ETF and Invesco QQQ, noting that cheaper, lower-risk market cap weighted options exist.

Will Apple's Foldable iPhone Flourish or Flop?

Apple unveiled its first foldable iPhone, called the iPhone Ultra, priced above $2,000 under new CEO John Ternus. The success of this premium device will be a key test for the new leadership, with investors monitoring pricing strategy, supply chain capacity, and competition from Samsung and Huawei. While the product could dominate a high-margin category if successful, Apple's core business remains strong enough that the foldable phone's performance won't make or break the company.

Alignment Health’s Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen

Alignment Health's 2026 survey reveals that 90% of seniors face at least one social barrier to healthy aging, with aging-in-place challenges, healthcare access issues, and economic instability as top concerns. The study shows worsening trends year-over-year, including increased difficulty maintaining independence and rising medical debt. Over one-quarter of seniors skipped needed medical care, with 34% citing aging-in-place challenges as the reason.

Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica

Nanox Imaging Ltd. (NASDAQ: NNOX) announced a distribution agreement with SOLME RC, S.A., a Costa Rica-based medical equipment distributor, to market and support the Nanox.ARC 3D imaging system. This marks Nanox's third Latin American market expansion this year, following Argentina and Peru. SOLME will handle marketing, distribution, installation, training, and technical support, with commercialization following a six-month regulatory POC device registration period.

Magnite and ITN Expand Partnership to Introduce Agentic AI Solution for Local Linear TV

Magnite and ITN have expanded their partnership to integrate agentic capabilities into local linear TV advertising through Magnite's Orchestration layer. The integration automates the buying process, reducing what traditionally takes multiple weeks into hours. By combining ITN's NXTv infrastructure with Magnite's ClearLine platform, the solution enables buyers to streamline planning, execution, and optimization of local linear and CTV inventory in a unified workflow, with full integration expected in Q4 2026.

StoneX and DeltaTerra Develop New Synthetic Structure for Agency Credit Risk Transfer

StoneX Financial Inc. and DeltaTerra Investments announced a synthetic credit risk transfer (CRT) transaction referencing Agency CRT securities from Fannie Mae's CAS program and Freddie Mac's STACR program. The structure uses a credit default swap framework to provide institutional investors alternative exposure to mortgage credit risk. DeltaTerra noted that approximately $19 billion of CRT bonds become eligible for call by end of Q3 2027, representing 44% of the outstanding market, positioning this transaction as a response to an anticipated supply inflection point.

Lowe's Just Hit a 52-Week Low. Is It an Obvious Buy or Should Investors Pause?

Lowe's stock has fallen 25% over the past year to a 52-week low of $199, driven by management's trimmed guidance citing macroeconomic pressures including high mortgage rates, inflation, and tariffs that have slowed DIY projects. While the company's fundamentals remain solid with growing Pro and digital segments, the stock presents a mixed opportunity: attractive for long-term dividend investors seeking a 2.45% yield, but lacking near-term catalysts for growth-oriented investors.

Cantor Fitzgerald Maintains Overweight on BitMine Immersion, Raises Price Target to $63.6

Cantor Fitzgerald analyst Gareth Gacetta maintains BitMine Immersion (NYSE:BMNR) with a Overweight and raises the price target from $30.6 to $63.6.

Biohaven shares are trading lower after the company announced the FDA ordered a pause on new enrollment in BHV-7000 program and issued a partial clinical hold on September 4, pending additional nonclinical metabolite data.

Oppenheimer Initiates Coverage On Aehr Test System with Outperform Rating, Announces Price Target of $120

Oppenheimer analyst Edward Yang initiates coverage on Aehr Test System (NASDAQ:AEHR) with a Outperform rating and announces Price Target of $120.

Barrington Research Initiates Coverage On CTS with Outperform Rating, Announces Price Target of $80

Barrington Research initiates coverage on CTS (NYSE:CTS) with a Outperform rating and announces Price Target of $80.